Literature DB >> 19339013

Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly.

Erik Ingelsson1, Johan Sundström, Håkan Melhus, Karl Michaëlsson, Christian Berne, Ramachandran S Vasan, Ulf Risérus, Rune Blomhoff, Lars Lind, Johan Arnlöv.   

Abstract

OBJECTIVE: Our aim was to examine relations of serum retinol-binding protein 4 (RBP4) to cardiovascular risk factors, and prevalent metabolic syndrome (MetS) and cardiovascular disease (CVD) in a large community-based sample of elderly.
METHODS: We evaluated cross-sectional relations of serum RBP4 to cardiovascular risk factors including anthropometrical measures, blood pressure, lipid measures, fasting glucose and insulin, body fat distribution including truncal fat by dual-energy x-ray absorptiometry (DXA), homeostasis model assessment insulin resistance (HOMA-IR) and prevalent MetS in one thousand eight 70-year old participants (50% women) of the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS), and in five hundred seven 82-year old men from Uppsala Longitudinal Study of Adult Men (ULSAM). In ULSAM, we also examined associations with prevalent CVD.
RESULTS: RBP4 concentrations were positively correlated with serum triglycerides (r=0.30; P<0.0001 in both samples), whereas correlations with body mass index (BMI), waist circumference, sagittal abdominal diameter, total and truncal fat mass, total cholesterol, fasting glucose and HOMA-IR were weak. In multivariable-adjusted models, RBP-4 was associated with MetS (odds ratio (OR), 1.16 and 1.33; 95% confidence interval (CI), 0.99-1.37 and 1.05-1.67 per 1-standard deviation (SD) increase in PIVUS and ULSAM, respectively), and prior cerebrovascular disease (OR, 1.37; 95% CI, 1.00-1.88 per 1-SD increase in ULSAM), but not with prior myocardial infarction.
CONCLUSION: In elderly, RBP4 concentrations were associated with MetS and its components in both sexes, and prior cerebrovascular disease in men. These findings are consistent with the hypothesis that circulating RBP4 could be a marker of metabolic complications and possibly also atherosclerosis and overt CVD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339013     DOI: 10.1016/j.atherosclerosis.2009.02.029

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  48 in total

Review 1.  [Adipokine update - new molecules, new functions].

Authors:  Carmen Gelsinger; Alexander Tschoner; Susanne Kaser; Christoph F Ebenbichler
Journal:  Wien Med Wochenschr       Date:  2010-08

2.  Increased unbound retinol-binding protein 4 concentration induces apoptosis through receptor-mediated signaling.

Authors:  Chao-Hung Chen; Tusty-Jiuan Hsieh; Kun-Der Lin; Hsing-Yi Lin; Mei-Yueh Lee; Wei-Wen Hung; Pi-Jung Hsiao; Shyi-Jang Shin
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

3.  Association of serum chemerin levels with the severity of coronary artery disease in patients with metabolic syndrome.

Authors:  Gökhan Aksan; Sinan İnci; Gökay Nar; Korhan Soylu; Ömer Gedikli; Serkan Yüksel; Metin Özdemir; Rukiye Nar; Murat Meriç; Mahmut Şahin
Journal:  Int J Clin Exp Med       Date:  2014-12-08

4.  Serum retinol binding protein 4 level is related with renal functions in Type 2 diabetes.

Authors:  E Akbay; N Muslu; E Nayir; O Ozhan; A Kiykim
Journal:  J Endocrinol Invest       Date:  2010-04-30       Impact factor: 4.256

5.  Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism.

Authors:  Julie Norseen; Tetsuya Hosooka; Ann Hammarstedt; Mark M Yore; Shashi Kant; Pratik Aryal; Urban A Kiernan; David A Phillips; Hiroshi Maruyama; Bettina J Kraus; Anny Usheva; Roger J Davis; Ulf Smith; Barbara B Kahn
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

6.  Plasma Levels of Fatty Acid-Binding Protein 4, Retinol-Binding Protein 4, High-Molecular-Weight Adiponectin, and Cardiovascular Mortality Among Men With Type 2 Diabetes: A 22-Year Prospective Study.

Authors:  Gang Liu; Ming Ding; Stephanie E Chiuve; Eric B Rimm; Paul W Franks; James B Meigs; Frank B Hu; Qi Sun
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-09-08       Impact factor: 8.311

Review 7.  Adipokines: a link between obesity and cardiovascular disease.

Authors:  Kazuto Nakamura; José J Fuster; Kenneth Walsh
Journal:  J Cardiol       Date:  2013-12-16       Impact factor: 3.159

8.  Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis.

Authors:  Christopher L Cioffi; Boglarka Racz; Andras Varadi; Emily E Freeman; Michael P Conlon; Ping Chen; Lei Zhu; Douglas B Kitchen; Keith D Barnes; William H Martin; Paul G Pearson; Graham Johnson; William S Blaner; Konstantin Petrukhin
Journal:  J Med Chem       Date:  2019-05-28       Impact factor: 7.446

9.  Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: a prospective analysis among women in the nurses' health study.

Authors:  Qi Sun; Urban A Kiernan; Ling Shi; David A Phillips; Barbara B Kahn; Frank B Hu; Joann E Manson; Christine M Albert; Kathryn M Rexrode
Journal:  Circulation       Date:  2013-04-12       Impact factor: 29.690

10.  Retinol-binding protein 4 induces inflammation in human endothelial cells by an NADPH oxidase- and nuclear factor kappa B-dependent and retinol-independent mechanism.

Authors:  Krysten M Farjo; Rafal A Farjo; Stacey Halsey; Gennadiy Moiseyev; Jian-Xing Ma
Journal:  Mol Cell Biol       Date:  2012-10-15       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.